Literature DB >> 35788276

Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.

Jonathan M Cohen1,2, Michael J Carter3,4, C Ronny Cheung5,6, Shamez Ladhani7,8.   

Abstract

Little is known about the MIS-C risk with different SARS-CoV-2 variants. In Southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in 0-16 years-olds were 56% lower (rate ratio, 0.34; 95%CI, 0.23-0.50) during pre-vaccine Delta, 66% lower (0.44; 0.28-0.69) during post-vaccine Delta and 95% lower (0.05; 0.02-0.10) during the Omicron period.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; MIS-C; PIMS-TS; SARS-CoV-2; coronavirus

Year:  2022        PMID： 35788276      PMCID： PMC9278259          DOI： 10.1093/cid/ciac553

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  5 in total

1.  COVID-19 vaccination for children aged 5-11 years.

Authors:  Shamez N Ladhani
Journal:  Lancet       Date:  2022-07-01       Impact factor: 202.731

2.  Evaluation of Baseline Characteristics and Prognostic Factors in Multisystemic Inflammatory Syndrome in Children: Is It Possible to Foresee the Prognosis in the First Step?

Authors:  Benhur Sirvan Cetin; Ayşenur Paç Kısaarslan; Sedanur Tekin; Merve Basol Goksuluk; Ali Baykan; Başak Nur Akyıldız; Yılmaz Seçilmiş; Hakan Poyrazoglu
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

3.  SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany.

Authors:  A L Sorg; V Schönfeld; A Siedler; M Hufnagel; M Doenhardt; N Diffloth; R Berner; R V Kries; J Armann
Journal:  Infection       Date:  2022-09-01       Impact factor: 7.455

4.  Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant.

Authors:  Laura Lopez; David Burgner; Catherine Glover; Jeremy Carr; Julia Clark; Alison Boast; Nan Vasilunas; Brendan McMullan; Joshua R Francis; Asha C Bowen; Christopher C Blyth; Kristine Macartney; Nigel W Crawford; Emma Carey; Nicholas Wood; Philip N Britton
Journal:  Lancet Reg Health West Pac       Date:  2022-10-07

5.  Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS).

Authors:  Jan David; Ondrej Hradsky; Petr Jabandziev; Eva Klaskova; Helena Jirincova; Jan Lebl
Journal:  J Paediatr Child Health       Date:  2022-10       Impact factor: 1.929
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.